Direct Peripheral Effects of Ghrelin Include Suppression of Adiponectin Expression

Abstract

The stomach-derived peptide, ghrelin, has recently been discovered as an important regulator of energy homeostasis. Central nervous system pathways involving stimulation of hypothalamic neuropeptides play a prominent role in mediating ghrelin’s orexigenic effects. However, potential direct peripheral effects remain poorly understood. Using a brown adipocyte model, we tested ghrelin-mediated influences on adipose tissue. Chronic ghrelin stimulation of differentiating adipocytes did not affect the pattern or extent of fat accumulation. Furthermore, insulin-induced glucose uptake as a hallmark of adipocyte function was not altered by ghrelin pre-treatment. However, acute ghrelin treatment resulted in a significant time-dependent increase in p44/42 mitogen-activated protein kinase phosphorylation. There was no stimulation of phosphatidylinositol 3-kinase, JAK/STAT, or stress kinase signaling pathways. Furthermore, ghrelin did not significantly alter gene expression of the thermogenic uncoupling protein-1. By contrast, expression of the novel adipokine adiponectin, which has been implicated in the pathogenesis of insulin resistance and obesity, was strongly impaired. This inhibition occurred acutely, and was sustained for several hours. In summary, our data provide evidence for selective effects of ghrelin on adipocyte signaling and function and thus propose a role for adipose tissue as a novel mediator of ghrelin’s effects on energy balance and glucose homeostasis.

Key words

Ghrelin - Brown Adipocyte - MAP Kinase - Adiponectin - Obesity - Insulin Resistance

References

• 1 Kojima M, Hosoda H, Kangawa K. Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor.  Horm Res. 2001;  56 Suppl. 1 93-97
• 2 Horvath T L, Diano S, Sotonyi P, Heiman M, Tschop M. Minireview: ghrelin and the regulation of energy balance - a hypothalamic perspective.  Endocrinology. 2001;  142 4163-4169
• 3 Toshinai K, Mondal M S, Nakazato M, Date Y, Murakami N, Kojima M, Kangawa K, Matsukura S. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration.  Biochem Biophys Res Commun. 2001;  281 1220-1225
• 4 Tschöp M, Weyer C, Tataranni P A, Devanarayan V, Ravussin E, Heiman M L. Circulating ghrelin levels are decreased in human obesity.  Diabetes. 2001;  50 707-709
• 5 Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl R L, Heiman M L, Lehnert P, Fichter M, Tschop M. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa.  Eur J Endocrinol. 2001;  145 669-673
• 6 Tschöp M, Wawarta R, Riepl R L, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C. Post-prandial decrease of circulating human ghrelin levels.  J Endocrinol Invest. 2001;  24 RC19-RC21
• 7 Wren A M, Seal L J, Cohen M A, Brynes A E, Frost G S, Murphy K G, Dhillo W S, Ghatei M A, Bloom S R. Ghrelin enhances appetite and increases food intake in humans.  J Clin Endocrinol Metab. 2001;  86 5992
• 8 Wren A M, Small C J, Abbott C R, Dhillo W S, Seal L J, Cohen M A, Batterham R L, Taheri S, Stanley S A, Ghatei M A, Bloom S R. Ghrelin causes hyperphagia and obesity in rats.  Diabetes. 2001;  50 2540-2547
• 9 Lawrence C B, Snape A C, Baudoin F M, Luckman S M. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers.  Endocrinology. 2002;  143 155-162
• 10 Tschop M, Smiley D L, Heiman M L. Ghrelin induces adiposity in rodents.  Nature. 2000;  407 908-913
• 11 Cummings D E, Purnell J Q, Frayo R S, Schmidova K, Wisse B E, Weigle D S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.  Diabetes. 2001;  50 1714-1719
• 12 Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats.  Diabetes. 2001;  50 2438-2443
• 13 Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.  Diabetes. 2001;  50 227-232
• 14 Tschop M, Statnick M A, Suter T M, Heiman M L. GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.  Endocrinology. 2002;  143 558-568
• 15 Klein J, Fasshauer M, Ito M, Lowell B B, Benito M, Kahn C R. beta(3)-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes.  J Biol Chem. 1999;  274 34 795-34 802
• 16 Klein J, Fasshauer M, Benito M, Kahn C R. Insulin and the beta3-adrenoceptor differentially regulate uncoupling protein-1 expression.  Mol Endocrinol. 2000;  14 764-773
• 17 Klein J, Fasshauer M, Klein H H, Benito M, Kahn C R. Novel adipocyte lines from brown fat: A model system for the study of differentiation, energy metabolism, and insulin action.  Bioessays. 2002;  24 382-388
• 18 Fasshauer M, Klein J, Ueki K, Kriauciunas K M, Benito M, White M F, Kahn C R. Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes.  J Biol Chem. 2000;  275 25 494-25 501
• 19 Fasshauer M, Klein J, Kriauciunas K M, Ueki K, Benito M, Kahn C R. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes.  Mol Cell Biol. 2001;  21 319-329
• 20 Jost P, Fasshauer M, Kahn C R, Benito M, Meyer M, Ott V, Lowell B B, Klein H H, Klein J. Atypical beta-adrenergic effects on insulin signaling and action in beta(3)-adrenoceptor-deficient brown adipocytes.  Am J Physiol Endocrinol Metab. 2002;  283 E146-E153
• 21 Ott V, Fasshauer M, Dalski A, Klein H H, Klein J. Direct effects of ciliary neurotrophic factor on brown adipocytes: evidence for a role in peripheral regulation of energy homeostasis.  J Endocrinol. 2002;  173 R1-R8
• 22 Tschop M, Flora D B, Mayer J P, Heiman M L. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats.  Obes Res. 2002;  10 991-999
• 23 Pfaffl M W. A new mathematical model for relative quantification in real-time RT-PCR.  Nucleic Acids Res. 2001;  29 E45
• 24 Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity.  Eur J Pharmacol. 2002;  440 235-254
• 25 Kojima M, Hosoda H, Matsuo H, Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor.  Trends Endocrinol Metab. 2001;  12 118-122
• 26 Toogood A A, Thornert M O. Ghrelin, not just another growth hormone secretagogue.  Clin Endocrinol (Oxf). 2001;  55 589-591
• 27 Flier J S, Maratos-Flier E. The stomach speaks-ghrelin and weight regulation.  N Engl J Med. 2002;  346 1662-1663
• 28 Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding.  Nature. 2001;  409 194-198
• 29 Wren A M, Small C J, Ward H L, Murphy K G, Dakin C L, Taheri S, Kennedy A R, Roberts G H, Morgan D G, Ghatei M A, Bloom S R. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion.  Endocrinology. 2000;  141 4325-4328
• 30 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.  Nature. 1999;  402 656-660
• 31 Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal M S, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion.  Diabetes. 2002;  51 124-129
• 32 Adeghate E, Ponery A S. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats.  J Neuroendocrinol. 2002;  14 555-560
• 33 Lee H M, Wang G, Englander E W, Kojima M, Greeley G H. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations.  Endocrinology. 2002;  143 185-190
• 34 Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, Kojima M, Kangawa K, Chihara K. Ghrelin modulates the downstream of insulin signaling in hepatoma cells.  J Biol Chem. 2002;  277 5667-5674
• 35 Gnanapavan S, Kola B, Bustin S A, Morris D G, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman A B, Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.  J Clin Endocrinol Metab. 2002;  87 2988
• 36 Kim M, Yoon C, Lee Y, Kim S, Kwon S, Shin C, Park K, Kim S, Cho B, Lee H. Ghrelin stimulates adipocyte proliferation through activation of the mitogen-activated protein kinase.  84th Annual Meeting of the Endocrine Society. San Francisco, USA; 2002
• 37 Kraus D, Fasshauer M, Ott V, Meier B, Jost M, Klein H H, Klein J. Leptin secretion and negative autocrine crosstalk with insulin in brown adipocytes.  J Endocrinol. 2002;  175 185-191
• 38 Berg A H, Combs T P, Scherer P E. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.  Trends Endocrinol Metab. 2002;  13 84-89
• 39 Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman M L, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.  Nat Med. 2001;  7 941-946
• 40 Berg A H, Combs T P, Du X, Brownlee M, Scherer P E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.  Nat Med. 2001;  7 947-953
• 41 Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.  Nat Med. 2002;  8 731-737
• 42 Müller A F, Janssen J A, Hofland L J, Lamberts S W, Bidlingmaier M, Strasburger C J, van der Lely A J. Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance.  J Clin Endocrinol Metab. 2001;  86 590-593
• 43 Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, Yamashita S, Miyagawa J, Funahashi T, Matsuzawa Y. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls.  Horm Metab Res. 2000;  32 47-50
• 44 Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis.  J Biol Chem. 2002;  277 37 487-37 491
• 45 Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes.  FEBS Lett. 2001;  507 142-146
• 46 Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes.  Biochem Biophys Res Commun. 2002;  290 1084-1089